{
    "status": "ok",
    "totalResults": 1,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "Allergan Aesthetics Announces Positive Topline Results from Second Phase 3 Study of OnabotulinumtoxinA (BOTOX\u00ae Cosmetic) for the Treatment of Platysma Prominence",
            "description": "(marketscreener.com) \n\n\u2013All primary and secondary endpoints were met for second Phase 3 study and results were consistent with findings from first Phase 3 study .\u2013Results support onabotulinumtoxinA as a potential treatment option for moderate to severe platys\u2026",
            "url": "https://www.marketscreener.com/quote/stock/ABBVIE-INC-12136589/news/Allergan-Aesthetics-Announces-Positive-Topline-Results-from-Second-Phase-3-Study-of-Onabotulinumtoxi-44867233/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-18T13:01:11Z",
            "content": "All primary and secondary endpoints were met for second Phase 3 study (M21-310) and results were consistent with findings from first Phase 3 study (M21-309).Results support onabotulinumtoxinA as a po\u2026 [+15862 chars]"
        }
    ]
}